Novyra Pharmachem shareholders and shareholding pattern
BSE: 519353Agricultural Food & other ProductsSmall Cap
Last close ₹8.50down ₹0.21 (2.41%)
Share price at the BSE close on 13 Oct 2026. Previous close ₹8.71.
52-week range of traded prices to 13 Oct 2026
₹6.47Low, 13 Oct 2025₹16.55High, 23 Mar 2026
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹5.38 Cr4,706th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 8 Aug 2026
- 9.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- −166.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −906.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 8 Aug 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 100
Who owns Novyra Pharmachem, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters23.15%
- Individuals and others76.85%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Individuals and others
| Per cent | Dec 2016Filed 22 Jan | Mar 2017Filed 30 Apr | Jun 2017Filed 18 Jul | Sep 2017Filed 24 Oct | Dec 2017Filed 22 Jan | Mar 2018Filed 2 May | Jun 2018Filed 17 Jul | Sep 2018Filed 19 Oct | Dec 2018Filed 23 Jan | Mar 2019Filed 12 Aug | Jun 2019Filed 12 Aug | Sep 2019Filed 2 Nov | Dec 2019Filed 14 Jan | Mar 2020Filed 18 May | Jun 2020Filed 25 Jul | Sep 2020Filed 16 Oct | Dec 2020Filed 22 Jan | Mar 2021Filed 21 Apr | Jun 2021Filed 22 Jul | Sep 2021Filed 20 Oct | Dec 2021Filed 22 Jan | Mar 2022Filed 22 Apr | Jun 2022Filed 20 Jul | Sep 2022Filed 20 Oct | Dec 2022Filed 20 Jan | Mar 2023Filed 20 Apr | Jun 2023Filed 20 Jul | Sep 2023Filed 18 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 21 Apr | Jun 2024Filed 20 Jul | Sep 2024Filed 21 Oct | Dec 2024Filed 21 Jan | Mar 2025Filed 19 Apr | Jun 2025Filed 21 Jul | Sep 2025Filed 29 Oct | Dec 2025Filed 16 Jan | Mar 2026Filed 21 Apr | Jun 2026Filed 21 Jul | Sep 2026Filed 21 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.42% | 35.42% | 35.42% | 35.42% | 35.42% | 35.42% | 35.42% | 35.42% | 35.42% | 26.64% | 26.64% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | |
| Indian promoters | 35.42% | 35.42% | 35.42% | 35.42% | 35.42% | 35.42% | 35.42% | 35.42% | 35.42% | 26.64% | 26.64% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% | 23.15% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 64.58% | 64.58% | 64.58% | 64.58% | 64.58% | 64.58% | 64.58% | 64.58% | 64.58% | 73.36% | 73.36% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% | 76.85% |
| Shares in issue | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,300 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,29,900 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 | 63,30,000 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 22,41,900 | 22,41,900 | 22,41,900 | 22,41,900 | 22,41,900 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Promoters' shares locked in | 22,41,900 | 22,41,900 | 22,41,900 | 22,41,900 | 22,41,900 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.
Novyra Pharmachem promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is BANSIDHAR MITRUKA AND SONS, 3.02%.
| Holder | |||
|---|---|---|---|
| BANSIDHAR MITRUKA AND SONSIndividuals and Hindu undivided families | 3.02% | 1,91,100 | 0 |
| S L AGARWAL AND SONSIndividuals and Hindu undivided families | 2.55% | 1,61,500 | 0 |
| AMIT MITRUKAIndividuals and Hindu undivided families | 1.79% | 1,13,600 | 0 |
| KAUSHALYA DEVI AGARWALIndividuals and Hindu undivided families | 1.25% | 79,400 | 0 |
| SAMAR LAL AGAEWALIndividuals and Hindu undivided families | 1.08% | 68,100 | 0 |
| S K AGARWAL AND SONS (H.U.F)Individuals and Hindu undivided families | 1.08% | 68,500 | 0 |
| INDRA DEVI AGARWALIndividuals and Hindu undivided families | 1.06% | 67,000 | 0 |
| SANDEEP KUMAR AGARWALIndividuals and Hindu undivided families | 1.00% | 63,500 | 0 |
| SUNIL AGARWALIndividuals and Hindu undivided families | 0.61% | 38,500 | 0 |
| HARISANKAR AGARWALIndividuals and Hindu undivided families | 0.51% | 32,000 | 0 |
| RAMLAL SHARMAIndividuals and Hindu undivided families | 0.47% | 30,000 | 0 |
| PANNA DEVI MITRUKAIndividuals and Hindu undivided families | 0.36% | 22,500 | 0 |
No promoter shares are reported as pledged. In demat is the part of the holding kept electronically; the rest is paper certificates.
Largest public holders of Novyra Pharmachem, filing by filing
Per cent, on the same shares as the split above.
| Holder | Sep 2019Filed 2 Nov | Dec 2019Filed 14 Jan | Mar 2020Filed 18 May | Jun 2020Filed 25 Jul | Sep 2020Filed 16 Oct | Dec 2020Filed 22 Jan | Mar 2021Filed 21 Apr | Jun 2021Filed 22 Jul | Sep 2021Filed 20 Oct | Dec 2021Filed 22 Jan | Mar 2022Filed 22 Apr | Jun 2022Filed 20 Jul | Sep 2022Filed 20 Oct | Dec 2022Filed 20 Jan | Mar 2023Filed 20 Apr | Jun 2023Filed 20 Jul | Sep 2023Filed 18 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 21 Apr | Jun 2024Filed 20 Jul | Sep 2024Filed 21 Oct | Dec 2024Filed 21 Jan | Mar 2025Filed 19 Apr | Jun 2025Filed 21 Jul | Sep 2025Filed 29 Oct | Dec 2025Filed 16 Jan | Mar 2026Filed 21 Apr | Jun 2026Filed 21 Jul | Sep 2026Filed 21 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEEPAKBHAI PRABHAKAR KAPREResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.68% | 1.68% | 1.68% | 1.68% | 1.68% |
| Hetal Shashank DoshiResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.67% | 1.67% | 1.67% | 1.67% | 1.67% |
| KAVYA DOSHIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% |
| DOSHI TEJResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.62% | 1.62% | 1.62% | 1.62% | 1.62% |
| KINJALBEN SNEHALKUMAR SHAHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% |
| TAPASYA KAMALKUMAR SHETHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.07% | 1.07% | 1.07% | 1.07% | 1.07% |
| MALJAK MARKResident individuals, over ₹2 lakh at face value | 1.68% | 1.68% | – | – | – | – | – | – | – | – | 1.68% | – | – | – | – | – | – | – | 1.68% | 1.68% | 1.68% | 1.68% | 1.68% | 1.68% | – | – | – | – | – |
| SABITRI T SANGMAResident individuals, over ₹2 lakh at face value | 1.67% | 1.67% | – | – | – | – | – | – | – | – | 1.67% | – | – | – | – | – | – | – | 1.67% | 1.67% | 1.67% | 1.67% | 1.67% | 1.67% | – | – | – | – | – |
| WELTHINGH R MARKResident individuals, over ₹2 lakh at face value | 1.63% | 1.63% | – | – | – | – | – | – | – | – | 1.63% | – | – | – | – | – | – | – | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | 1.63% | – | – | – | – | – |
| BANSIDHAR MITRUKA & OTHERSResident individuals, over ₹2 lakh at face value | 1.14% | 1.14% | – | – | – | – | – | – | – | – | 1.14% | – | – | – | – | – | – | – | 1.14% | 1.14% | 1.14% | 1.14% | 1.14% | 1.62% | – | – | – | – | – |
| TULIKA AGARWALResident individuals, over ₹2 lakh at face value | 1.62% | 1.62% | – | – | – | – | – | – | – | – | 1.62% | – | – | – | – | – | – | – | 1.62% | 1.62% | 1.62% | 1.62% | 1.62% | 1.14% | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.